Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Gsk2140944
1. 1075236-89-3
2. Gsk2140944
3. Gsk-2140944
4. Gsk 2140944
5. Dvf0pr037d
6. 3h,8h-2a,5,8a-triazaacenaphthylene-3,8-dione, 2-((4-(((3,4-dihydro-2h-pyrano(2,3-c)pyridin-6-yl)methyl)amino)-1-piperidinyl)methyl)-1,2-dihydro-, (2r)-
7. (2r)-2-[(4-{[(3,4-dihydro-2h-pyrano[2,3-c]pyridin- 6-yl)methyl]amino}piperidin-1-yl)methyl]-1,2-dihydro- 3h,8h-2a,5,8a-triazaacenaphthylene-3,8-dione
8. (3~{r})-3-[[4-(3,4-dihydro-2~{h}-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.0^{4,12}]dodeca-6,8(12),9-triene-5,11-dione
9. (3r)-3-[[4-(3,4-dihydro-2h-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.04,12]dodeca-6,8(12),9-triene-5,11-dione
10. Gepotidacin [usan:inn]
11. Unii-dvf0pr037d
12. 3h,8h-2a,5,8a-triazaacenaphthylene-3,8-dione, 2-[[4-[[(3,4-dihydro-2h-pyrano[2,3-c]pyridin-6-yl)methyl]amino]-1-piperidinyl]methyl]-1,2-dihydro-, (2r)-
13. Jhn
14. Gepotidacin [inn]
15. Gepotidacin (usan/inn)
16. Gepotidacin [usan]
17. Gepotidacin [who-dd]
18. Schembl3332319
19. Chembl3317856
20. Gtpl10817
21. Dtxsid501028208
22. Bdbm50050549
23. Gsk 2140944e
24. Cs-6531
25. Db12134
26. Hy-16742
27. D10878
28. A857306
29. Q19597285
| Molecular Weight | 448.5 g/mol |
|---|---|
| Molecular Formula | C24H28N6O3 |
| XLogP3 | 0.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 448.22228878 g/mol |
| Monoisotopic Mass | 448.22228878 g/mol |
| Topological Polar Surface Area | 90.4 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 893 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of uncomplicated urogenital gonorrhea
Treatment of uncomplicated urinary tract infections
Topoisomerase Inhibitors
Compounds that inhibit the activity of DNA TOPOISOMERASES. (See all compounds classified as Topoisomerase Inhibitors.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
APIs
Reply
03 May 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
A Gepotidacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gepotidacin, including repackagers and relabelers. The FDA regulates Gepotidacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gepotidacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Gepotidacin supplier is an individual or a company that provides Gepotidacin active pharmaceutical ingredient (API) or Gepotidacin finished formulations upon request. The Gepotidacin suppliers may include Gepotidacin API manufacturers, exporters, distributors and traders.
Gepotidacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gepotidacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gepotidacin GMP manufacturer or Gepotidacin GMP API supplier for your needs.
A Gepotidacin CoA (Certificate of Analysis) is a formal document that attests to Gepotidacin's compliance with Gepotidacin specifications and serves as a tool for batch-level quality control.
Gepotidacin CoA mostly includes findings from lab analyses of a specific batch. For each Gepotidacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gepotidacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Gepotidacin EP), Gepotidacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gepotidacin USP).
LOOKING FOR A SUPPLIER?
Comment (5)
